van den Boom Rivka, Lesnik Oberstein Saskia A, Spilt Aart, Behloul Faiza, Ferrari Michel D, Haan Joost, Westendorp Rudi G, van Buchem Mark A
Department of Radiology, Leiden University Medical Center, Leiden, The Netherlands.
J Cereb Blood Flow Metab. 2003 May;23(5):599-604. doi: 10.1097/01.WCB.0000062341.61367.D3.
Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) is a hereditary small-vessel disease caused by mutations in the NOTCH3 gene on chromosome 19. On magnetic resonance imaging (MRI), subcortical white matter hyperintensities and lacunar infarcts are visualized. It is unknown whether a decrease in cerebral blood flow or cerebrovascular reactivity is primarily responsible for the development of white matter hyperintensities and lacunar infarcts. The authors used phase-contrast MRI in 40 NOTCH3 mutation carriers (mean age 45 +/- 10 years) and 22 nonmutated family members (mean age 39 +/- 12 years), to assess baseline total cerebral blood flow (TCBF) and cerebrovascular reactivity after acetazolamide. Mean baseline TCBF was significantly decreased in NOTCH3 mutation carriers. In young subjects, baseline TCBF was significantly lower than in nonmutation carriers (mean difference 124 mL/min). Furthermore, baseline TCBF did not differ significantly between mutation carriers with minimal and mutation carriers with moderate or severe white matter hyperintensities. No significant difference in mean cerebrovascular reactivity was found between mutation carriers and nonmutation carriers. This study suggests that a decrease in baseline TCBF in NOTCH3 mutation carriers precedes the development of white matter hyperintensities.
伴有皮质下梗死和白质脑病的脑常染色体显性动脉病(CADASIL)是一种由19号染色体上NOTCH3基因突变引起的遗传性小血管疾病。在磁共振成像(MRI)上,可以看到皮质下白质高信号和腔隙性梗死。目前尚不清楚脑血流量或脑血管反应性的降低是否是导致白质高信号和腔隙性梗死的主要原因。作者对40名NOTCH3突变携带者(平均年龄45±10岁)和22名未突变的家庭成员(平均年龄39±12岁)进行了相位对比MRI检查,以评估基线全脑血流量(TCBF)和乙酰唑胺给药后的脑血管反应性。NOTCH3突变携带者的平均基线TCBF显著降低。在年轻受试者中,基线TCBF显著低于未突变携带者(平均差异124 mL/min)。此外,白质高信号轻微的突变携带者与白质高信号中度或重度的突变携带者之间的基线TCBF没有显著差异。突变携带者和未突变携带者之间的平均脑血管反应性没有显著差异。这项研究表明,NOTCH3突变携带者的基线TCBF降低先于白质高信号的出现。